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Abstract The propeptide of subtilisin-family proteases is known 
to exhibit inhibitory activity toward a cognate protease in 
addition to its function as an intramolecular chaperone. For 
detailed investigation of its inhibitory properties, the propeptide 
of subtilisin BPN' was produced in Escherichia coli. Inhibitory 
activity measurements and electrophoresis showed that the 
propeptide was a temporary inhibitor, which was initially potent 
but was gradually degraded by subtilisin BPN' through specific 
intermediates. The main cleavage site was identified as Glu53-
Lys54, with minor sites at Thr17-Met18 and Met21-Ser22, which 
were located in turn regions of the propeptide in the complex with 
subtilisin BPN'. Since the isolated propeptide has been shown not 
to form a tertiary structure, these results indicate that main 
digestions proceed through proteolytic attack of subtilisin toward 
the accessible sites of the propeptide in the complex with 
subtilisin. Therefore, replacement of Glu53 at the main cleavage 
site by Asp, which is a less favorable amino acid than Glu for 
subtilisin, makes the propeptide a more resistant temporary 
inhibitor. 
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1. Introduction 
Subtilisin BPN' is an alkaline protease secreted by Bacillus 
amyloliquefaciens, and produced from a precursor protein 
which possesses a prosequence composed of 77 residues be-
tween a presequence functioning as a signal peptide and a 
mature region of subtilisin. It has been demonstrated that 
the prosequence (or propeptide) is an intramolecular chaper-
one required for proper folding of subtilisin in vivo and in 
vitro [1], based on findings that the subtilisin gene which lacks 
the prosequence produces a mature but inactive form of sub-
tilisin in vivo [2] and that the refolding efficiency of denatured 
subtilisin is markedly increased by covalent attachment of the 
propeptide to mature subtilisin [3,4] or exogenous addition of 
the propeptide to the solution [5,6]. In addition to its function 
as a chaperone, the propeptide of subtilisin has been shown to 
exhibit inhibitory activity toward subtilisin with an inhibitor 
constant of about 1CT9 M [5,7-9]. Although it is initially 
potent, the propeptide is degraded by subtilism [9], and thus 
has been termed a temporary inhibitor. Furthermore, a rela-
tionship between the chaperone ability of the propeptide and 
its inhibitory activity has also been demonstrated [8]. How-
ever, details of the degradation process of the propeptide by 
subtilisin, such as identification of the cleavage sites, are not 
well understood. 
*Corresponding author. Fax: +81 (3) 5992-1034. 
We have been carrying out structure-function relationship 
studies of protease inhibitors to clarify the mechanisms by 
which they inhibit proteases using site-specific mutants of 
Streptomyces subtilisin inhibitor (SSI) [10-13], ovomucoid do-
main 3 [14] and Cucurbita maxima trypsin inhibitor I (CMTI-
I) [15] and natural mutants (SIL proteins) [16,17] of SSI. The 
results have suggested that conformational rigidity and high 
stability are required for permanent (not temporary) inhibi-
tion. In addition, we have shown that almost complete rena-
turation of denatured subtilisin BPN' can be accomplished 
using organic salts and mutated SSI, which had been con-
verted to a digestible temporary inhibitor by removal of the 
disulfide bridge near the reactive site [18]. 
Based on these findings, we have considered that by succes-
sive amino acid replacements, it might be possible to make 
mutant proteins from the propeptide which exhibit permanent 
inhibition of subtilisin. Such studies would clarify not only the 
molecular mechanisms responsible for temporary inhibition of 
the propeptide, but also those responsible for inhibition of 
protease inhibitors toward proteases. In this study, as a first 
step toward achieving such functional alteration of the pro-
peptide to a resistant form, we identified the cleavage site of 
the propeptide by subtilisin BPN' by sequence analysis of 
degradation intermediates, and examined the effects of amino 
acid replacements at the identified main cleavage site on the 
inhibitory properties of the propeptide. 
2. Materials and methods 
2.1. Materials 
Restriction enzymes and DNA-modifying enzymes were purchased 
from Takara Shuzo, Toyobo and Boehringer Mannheim (Germany). 
Subtilisin BPN' was obtained from Sigma (St. Louis, MO, USA). 
Other chemicals were of reagent grade for biochemical research. 
2.2. Construction of the propeptide expression system 
Since we had already cloned the subtilisin gene which encodes a 
precursor form from B. amyloliquefaciens [19], the DNA fragment 
encoding the propeptide portion of subtilisin BPN' was amplified by 
the polymerase chain reaction. Primers with sequences of 5'-AAAC-
CATGGCAGGGAAATCAAACGGGGAAAAGAAAT-3' and 5'-
AAAGGATCCTTAGTACGCATGTGCTACGTGATCTTCTTC-3' 
were designed to introduce the Ncol site and an initiation codon, and 
a stop codon and the BamHI site, respectively. An amplified fragment 
was digested with Ncol and BamHI, and inserted into the Ncol-Bam-
HI site of plasmid pTVl 19N to produce pTVPRO. After confirmation 
of the nucleotide sequence by dideoxy sequencing, the cloned propep-
tide gene was inserted into the NcoI-BamHI site of pETlld, which 
possesses a promoter of T7 RNA polymerase [20]. 
2.3. Expression and purification of the propeptide 
Escherichia coli BL21(DE3) was transformed by the constructed 
expression plasmid. Large-scale culture in LB medium containing 50 
ug/ml ampicillin was started by inoculation of a small-scale overnight 
culture. When Agoo reached 1, expression of the propeptide gene was 
induced by addition of isopropyl-p-D-galactopyranoside to give a final 
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concentration of 0.4 mM, followed by culture for 2 h. Cells suspended 
in 10 mM Tris-HCl/0.1 mM EDTA (pH 8.0) were disrupted by ultra-
sonication. The cell lysate collected by centrifugation at 10000 rpm 
was diluted with a 50 mM sodium acetate buffer (pH 5.5), and applied 
to a CM-52 column (2x15 cm). After washing the column, the pro-
peptide was eluted with a linear gradient of 0-1 M NaCl. To improve 
the purity, the eluted propeptide was subjected to reverse-phase 
HPLC on a C18 column (L-column ODS, 4X 150 mm) with an ace-
tonitrile gradient. 
2.4. Determination of protein concentration 
Protein concentrations were determined spectrophotometrically us-
ing an A1%280 of 11-7 for subtilisin BPN' [21] and a molar absorption 
coefficient constant feso) of 5120 [4] for the propeptide. 
2.5. Inhibitory activity of the propeptide toward subtilisin BPN' 
Subtilisin BPN' at 364 nM and various molar ratios of propeptide 
were incubated at 25°C in 0.1 M Tris-HCl (pH 8.0). At 0, 10, 30, 50 
min, an aliquot of 100 itl containing lug of subtilisin was withdrawn 
and added to 900 ul of 0.111 mM succinyl-L-Ala-L-Ala-L-Pro-L-Phe 
p-nitroanilide in the buffer, followed by monitoring of the absorbance 
at 410 nm. The inhibitory activity was defined as [1— (F;/Fo)]Xl00 
(%), where V\ and VQ are the activity of subtilisin in the presence and 
absence of the propeptide, respectively. For the 0 min incubation, V\ 
was obtained after the equilibrium of subtilisin-propeptide complex 
formation had been attained. 
2.6. Electrophoretic analysis of the propeptide-subtilisin mixture 
Subtilisin BPN' at 364 nM and a 25-fold molar excess of the pro-
peptide (9.1 (xM) were incubated at 25°C in 0.1 M Tris-HCl (pH 8.0). 
After 0.5, 30, 60, 90 and 120 min of incubation, an ahquot (50 ul) of 
the mixture containing 0.5 ug of subtilisin was withdrawn. The pro-
teins were precipitated with trichloroacetic acid at a final concentra-
tion of 20%, followed by washing with acetone, and then subjected to 
SDS-polyacrylamide gel electrophoresis. 
2.7. Isolation of degradation intermediates of the propeptide and 
sequence analysis 
Subtilisin (64 |ig, 2.33 nmol) and propeptide (784 ug, 92.7 nmol) 
were incubated at 25°C for 20 min in 1.6 ml of 0.1 M Tris-HCl (pH 
8.0). The proteins were then precipitated and subjected to reverse-
phase HPLC on a C18 column, as described above. Isolated degra-
dation intermediates were subjected to an Applied Biosystems Protein 
Sequencer model 476A (Foster City, CA, USA) to determine their 
amino-terminal sequences. The carboxy-terminal sequences were ana-
lyzed using a Hewlett-Packard model G1009A C-terminal protein 
sequencer (Palo Alto, CA, USA), which utilizes diphenyl phospho-
roisothianatidate as a coupling reagent [22]. The major degradation 
intermediate (3 nmol) was digested with endoproteinase Asp-N using 
a substrate/enzyme ratio of 100 at 37°C overnight in 0.5 M urea/ 50 
mM sodium phosphate (pH 8.0). The digested fragments were sepa-
rated using reverse-phase HPLC on a C18 column, as described 
above. 
2.8. Site-directed mutagenesis 
E. coli CJ236 was transformed with a plasmid pTVPRO, and single-
stranded DNA containing uracil bases was obtained by infection with 
the helper phage M13K07. Replacement of the codon for Glu53 from 
GAA to GAT was carried out using a primer with a sequence of 5'-
ACATTAAACGAT*AAAGCTGTAAA-3', where the asterisk indi-
cates the mismatched base, according to the method of Kunkel [23], 
The mutation was verified by dideoxy sequencing, and the mutated 
gene was inserted into pETlld, as described for the wild type. 
3. Results 
3.1. Expression and characterization of the propeptide of 
subtilisin BPN' 
Our expression system for the propeptide was essentially the 
same as that used by other groups, i.e. a pET system which 
utilized the promoter of T7 RNA polymerase inducible by 
IPTG [20]. The propeptide was expressed in the soluble frac-
tion of E. coli, and purified by chromatography after disrup-
tion of E. coli by sonication. The yield was about 1.8 mg from 
1 liter of E. coli culture. Amino-terminal sequence analysis 
showed that the expressed propeptide lacked the amino-termi-
nal Met residue. Measurement of the circular dichroism spec-
tra indicated that the propeptide did not have any typical 
secondary structures (data not shown), as described by other 
groups [4,7,24]. 
Then, the inhibitory activities of the propeptide toward 
subtilisin BPN' at various ratios were measured using a syn-
thetic substrate. As shown in Fig. 1(A), the propeptide was 
(A) 
4 e a io 
[Propeptide3/[SubtiJisin](mo(/moO 
(B) 
Q5 30 60 90 120 (min) 
^-Subtilisin 
^ » ^ - T - <- Propept id e 
Fig. 1. Inhibitory activity (A) and electrophoretic pattern (B) of the 
wild-type propeptide in the reaction mixture with subtilisin BPN'. 
(A) Subtilisin BPN' at 364 nM and various molar ratios of the pro-
peptide were incubated at 25°C in 0.1 M Tris-HCl (pH 8.0). At 
0 min (o), 10 min ( A ) , 30 min (□) and 50 min ( v ) of incubation, 
a 100-(xl aliquot was withdrawn and the inhibitory activity was 
measured using a synthetic substrate. (B) Subtilisin BPN' at 364 
nM and a 25-fold molar excess of the propeptide were incubated at 
25°C in 0.1 M Tris-HCl (pH 8.0). At the indicated time, the pro-
teins in a 50-jo.l aliquot were precipitated with trichloroacetic acid 
and subjected to SDS-polyacrylamide gel electrophoresis (gel con-
centration 18.8%). 
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Fig. 2. Chromatogram of the subtilisin-digested propeptide on reverse-phase HPLC. Subtilisin (64 ug) and a 40-fold molar excess of the pro-
peptide were incubated at 25°C for 20 min in 1.6 ml of 0.1 M Tris-HCl (pH 8.0). The proteins were precipitated with trichloroacetic acid, and 
subjected to reverse-phase HPLC on a C18 column (L-column ODS) using an acetonitrile gradient. 
initially a potent inhibitor. However, as the incubation time 
from mixing the propeptide and subtilisin to addition of the 
substrate was increased, the inhibitory activities showed an 
evident decrease. Even at a molar ratio of 7, the inhibitory 
activity of the propeptide was completely lost after 30 min of 
incubation. This phenomenon is typical of that for a tempo-
rary inhibitor. 
Since this time-dependent decrease of inhibitory activity 
was considered to result from degradation of the propeptide 
by protease, as demonstrated for a mutated SSI which was 
converted to a temporary inhibitor, the molecular state of the 
propeptide in the reaction mixture with subtilisin BPN' was 
investigated by SDS-polyacrylamide gel electrophoresis. 
As shown in Fig. 1(B), the band of the propeptide became 
thinner as the incubation time increased. Concurrently, two 
bands which were considered to be degradation intermedi-
ates appeared below the authentic band of the propeptide; 
one was a rapidly migrating major band and the other was 
a minor band located between the propeptide and the rapid-
ly migrating major band. These results clearly showed that 
the propeptide is a temporary inhibitor which is initially 
potent, but degraded by subtilisin through specific intermedi-
ates. 
3.2. Identification of the cleavage sites in the propeptide 
In order to clarify the process of propeptide degradation by 
subtilisin, degradation intermediates were isolated using re-
verse-phase HPLC. Fig. 2 shows a chromatogram of the pro-
tein sample prepared from a 20 min incubated mixture com-
posed of subtilisin and 40-fold molar excess of the propeptide. 
Electrophoretic analysis indicated that peaks a and b corre-
sponded to the major and minor intermediates, respectively, 
and peak c to the authentic propeptide. The relatively low 
amount of peak c, compared with the result of Fig. 1(B), 
seems to be differences in the conditions (molar ratio and 
concentration) of the subtilisin-propeptide mixture. The iso-
lated peptides were subjected to sequence analysis to identify 
the cleavage sites. 
The arnmo-terminal sequence of the major intermediate was 
the same as that of the authentic propeptide, while Glu was 
identified as the carboxy-terminal residue of the intermedi-
ate. Since the propeptide possesses 6 Glu residues, the car-
boxy-terminal sequence was investigated by sequence analysis 
of its enzymatic digests. Digestion of the major intermedi-
ate by endoproteinase Asp-N produced 3 peaks on re-
verse-phase HPLC. Sequence analysis indicated that peaks 
1, 2 and 3 corresponded to Asp45-Glu53, Asp28-Val44 and 
Ala^Lys27, respectively. These results clearly indicated 
that the major degradation intermediate corresponded to 
Ala^Glu5 3 of the propeptide, and thus the major specific 
cleavage of the propeptide by subtilisin occurred at Glu53-
Lys54. 
On the other hand, the carboxy-terminal sequence of the 
minor intermediate (-His-Val-Ala-His-Ala-Tyr) was the 
same as that of the authentic propeptide, while the main ami-
no-terminal sequences were Met-Ser-Thr-Met-Ser-Ala-Ala-
and Ser-Ala-Ala-Lys-Lys-Lys-Asp-, corresponding to the 
18th-24th and 22nd-28th residues of the propeptide, respec-
tively. Thus, the minor specific cleavage occurred at Thr17-
Met18 and Met21-Ser22. In addition, the sequences starting 
from the 15th and 25th residues of the propeptide were de-
tected as minor sequences of the minor intermediates, indicat-
ing cleavages at Phe14-Ser15 and Ala24-Lys25. No other pep-
tide fragments were detected, indicating that subsequent 
degradation of the propeptide after the specific cleavages pro-
ceeded randomly. 
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Fig. 3. Inhibitory activity (A) and electrophoretic pattern (B) of the 
mutated propeptide in the reaction mixture with subtilisin BPN'. 
The conditions were the same as those described for the wild type 
in Fig. 1. 
3.3. Effects of an amino acid replacement on the properties of 
the propeptide 
In order to make the propeptide more resistant to proteo-
lytic degradation, Glu53 identified as the major cleavage site in 
the degradation intermediates was replaced. Although Glu is 
an unfavorable amino acid substrate of subtilisin BPN' [25], 
Asp or Pro has been considered to be more resistant to diges-
tion by subtilisin BPN' from studies on the interaction of Pl-
site mutants of SSI and subtilisin BPN' [11]. Since Pro has an 
irregular main-chain configuration, Asp was introduced as the 
53rd residue of the propeptide. 
Fig. 3 shows the inhibitory activities and molecular states of 
the mutated propeptide in the reaction mixture with subtilisin 
BPN' at various incubation times after mixing. The mutated 
propeptide was degraded by subtilisin BPN' more slowly than 
the wild type, and consequently the rate of decrease in inhib-
itory activity of the mutated propeptide was slower than that 
of the wild type. Thus, it was shown that the replacement 
Glu53 -> Asp at the main cleavage site of the propeptide 
made the propeptide more resistant to proteolytic digestion 
by subtilisin. The CD spectrum of the mutated propeptide 
was the same as that of the wild type (data not shown). 
4. Discussion 
The propeptide of subtilisin-family proteases is a unique 
protein because it exhibits inhibitory activity toward a cog-
nate protease in addition to its function as an intramolecular 
chaperone. Although it has also been demonstrated that the 
propeptide is a temporary inhibitor which is initially potent 
but gradually degraded by protease, subsequent detailed anal-
yses of the propeptide as a protease inhibitor have not been 
carried out. In this study, we therefore attempted to clarify the 
process of degradation of the propeptide and then to convert 
it to a more resistant inhibitor. 
Electrophoretic analysis of the subtilisin-propeptide mix-
ture clearly indicated that the propeptide was degraded by 
subtilisin through specific intermediates which appeared as a 
main and minor bands, and that consequently the inhibitory 
activity of the propeptide toward subtilisin decreased as the 
incubation time was prolonged. We then identified the cleav-
age sites of the propeptide by sequence analysis of the degra-
dation intermediates purified by HPLC. 
The main cleavage site was identified as Glu53-Lys54, which 
was unexpected because Glu is an unfavorable amino acid 
substrate of subtilisin BPN' [25]. We then considered the rea-
son for the cleavage at position 53 from the viewpoint of the 
three-dimensional structure. It has been demonstrated that, 
although the isolated propeptide hardly exhibits typical sec-
ondary and tertiary structures, it forms a defined tertiary 
structure by complex formation with inactive subtilisin in 
which there is Ser221 -> Ala or Cys replacement at the active 
site [4,7,24]. The tertiary structure of the propeptide in the 
complex has been clarified by X-ray crystallography [26,27]. 
According to the revealed structure of the propeptide, Glu53 is 
located just at the turn region between the p3-strand and oc2-
helix, and thus is considered to be accessible to the proteolytic 
attack by subtilisin. If Glu53 is not at this location, a specific 
intermediate may not be detected, because many amino acids 
that are favorable as substrates of subtilisin BPN' exist 
around Glu53. In other words, cleavage at Glu53 is considered 
to occur toward the propeptide molecule that is complexed 
with subtilisin by another subtilisin molecule in an uncom-
plexed state. 
The identified minor cleavage sites Thr17-Met18 and Met21-
Ser22 are also located just in the turn region between the Pi-
strand and ai-helix of the propeptide complexed with subtili-
sin BPN'. Since Met and Thr are more favorable amino acids 
than Glu [25], it is considered that cleavage at Thr1T-Met18 
and Met21-Ser22 proceeds more rapidly, and thereby the deg-
radation product appears as a minor band. In contrast, minor 
cleavage sites in the minor intermediates were located in the 
secondary structures in the interior of the propeptide mole-
cule. This situation, and the fact that these amino acids are 
favorable for subtilisin BPN', indicate that the cleavage at 
these sites may proceed when the uncomplexed propeptide is 
in a random-coil state. However, we could not explain why 
other intermediates produced by cleavage at more favorable 
sites were not detected. On the basis of these considerations, 
two pathways in the degradation of the propeptide by sub-
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tilisin BPN' can be proposed: main cleavage at very accessible 
sites in the complex with subtilisin, and minor cleavage at the 
favorable residues in the random-coil state. 
We then substituted Asp for Glu53 at the main cleavage site 
in order to make the propeptide more resistant to proteolytic 
digestion. As expected, the time-dependent inhibitory activity 
and electrophoretic pattern showed that the mutated propep-
tide became more resistant to digestion by subtilisin BPN'. 
Since the CD spectra indicated that hardly any structural 
change resulted from the replacement, conversion of the pro-
peptide to a more resistant inhibitor was due to the resistance 
of the Asp residue at position 53 to proteolytic attack by 
subtilisin BPN'. Thus, the Glu53 ->Asp replacement in this 
study was demonstrated effective for converting the propep-
tide to a more resistant inhibitor. However, studies using oth-
er approaches will be required for subsequent conversion, and 
these are now in progress. 
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